Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production

This publication has 48 references indexed in Scilit:

• Nitric oxide production by human monocytes: evidence for a role of CD23
  Immunology Today, 1995
• Macrophage Priming and Activation During Fibrosarcoma Growth: Expression of c-myb, c-myc, c-fos, and c-fms
  Immunological Investigations, 1994
• Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages.
  The Journal of Experimental Medicine, 1993
• The Pathophysiology of Tumor Necrosis Factors
  Annual Review of Immunology, 1992
• Effects of Taxol on the Macrophage Function. Interactions with Some Immunological Parameters
  Immunopharmacology and Immunotoxicology, 1992
• Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Shared Actions of Endotoxin and Taxol on TNF Receptors and TNF release
  Science, 1990
• Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
• Nitric oxide: A cytotoxic activated macrophage effector molecule
  Biochemical and Biophysical Research Communications, 1988
• Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1986